Abante, Joel P.

HRN: 06-56 - 95  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2022
AZITHROMYCIN 500MG TABLET (TAB)
04/23/2022
04/30/2022
PO
500mg
OD
Pneumonia
Waiting Final Action 
04/23/2022
CEFUROXIME 1.5GM (VIAL)
04/23/2022
04/30/2022
IV
1.5g
Q8H
Pneumonia
Waiting Final Action 
04/25/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/25/2022
05/02/2022
IV
1.5gms
Q6
CAP MR
Waiting Final Action 
04/30/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/30/2022
05/07/2022
IV
4.5g
Q6
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: